Published in EMBO J on January 01, 1982
Site of addition of N-acetyl-galactosamine to the E1 glycoprotein of mouse hepatitis virus-A59. J Cell Biol (1988) 2.49
Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res (1985) 2.37
Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. J Virol (1985) 2.34
Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol (1986) 2.24
Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol (1990) 2.21
Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J Virol (1991) 2.16
Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase. Mol Cell Biol (1990) 2.06
Cytoplasmic domains of cellular and viral integral membrane proteins substitute for the cytoplasmic domain of the vesicular stomatitis virus glycoprotein in transport to the plasma membrane. J Cell Biol (1986) 1.88
Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol (1998) 1.74
Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors. Proc Natl Acad Sci U S A (1988) 1.62
Cytochemical localization of terminal N-acetyl-D-galactosamine residues in cellular compartments of intestinal goblet cells: implications for the topology of O-glycosylation. J Cell Biol (1984) 1.61
Assembly of coronavirus spike protein into trimers and its role in epitope expression. J Virol (1990) 1.60
Coronavirus E1 glycoprotein expressed from cloned cDNA localizes in the Golgi region. J Virol (1987) 1.41
Inhibition of proteolytic cleavage of the hemagglutinin of influenza virus by the calcium-specific ionophore A23187. EMBO J (1984) 1.32
Subcellular localization of the UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-mediated O-glycosylation reaction in the submaxillary gland. Proc Natl Acad Sci U S A (1994) 1.31
The carbohydrates of mouse hepatitis virus (MHV) A59: structures of the O-glycosidically linked oligosaccharides of glycoprotein E1. EMBO J (1984) 1.24
Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus. J Virol (1989) 1.21
Two enzymes involved in the synthesis of O-linked oligosaccharides are localized on membranes of different densities in mouse lymphoma BW5147 cells. J Cell Biol (1984) 1.20
Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion. J Virol (1999) 1.19
Assembly in vitro of a spanning membrane protein of the endoplasmic reticulum: the E1 glycoprotein of coronavirus mouse hepatitis virus A59. Proc Natl Acad Sci U S A (1984) 1.18
Effects of preventing O-glycosylation on the secretion of human chorionic gonadotropin in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1987) 1.14
Structural maturation of the transmissible gastroenteritis coronavirus. J Virol (1999) 1.13
Effect of monensin on the assembly of Uukuniemi virus in the Golgi complex. J Virol (1985) 1.12
Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry. J Virol (2007) 1.04
Early O-glycosidic glycosylation of proglucagon in pancreatic islets: an unusual type of prohormonal modification. EMBO J (1986) 0.90
The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation. J Neurosci (2013) 0.89
GxxxG motif of severe acute respiratory syndrome coronavirus spike glycoprotein transmembrane domain is not involved in trimerization and is not important for entry. J Virol (2007) 0.79
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Immunocytochemical localization of galactosyltransferase in HeLa cells: codistribution with thiamine pyrophosphatase in trans-Golgi cisternae. J Cell Biol (1982) 6.67
Intracellular transport of secretory and membrane proteins in hepatoma cells infected by vesicular stomatitis virus. Cell (1980) 4.15
Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J Virol (1980) 3.82
The role of cytoplasmic membranes in poliovirus biosynthesis. Virology (1970) 3.46
Vesicular stomatitis virus and sindbis virus glycoprotein transport to the cell surface is inhibited by ionophores. Virology (1980) 3.13
Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion. Virology (1982) 2.94
Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins. J Cell Biol (1980) 2.50
Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein. Virology (1981) 2.34
Plasma cell immunoglobulin M molecules. Their biosynthesis, assembly, and intracellular transport. J Cell Biol (1979) 2.29
Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J Virol (1981) 2.27
Activation of lysosomal enzymes in virus-infected cells and its possible relationship to cytopathic effects. J Exp Med (1963) 2.18
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
The polypeptides of adenovirus. VI. Early and late glycopolypeptides. Virology (1974) 1.98
Cross-linking of the components of lactose synthetase with dimethylpimelimidate. J Biol Chem (1975) 1.98
Membrane-associated replication complex in arbovirus infection. J Virol (1972) 1.83
Coronavirus glycoprotein E1, a new type of viral glycoprotein. J Mol Biol (1981) 1.55
Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E). J Virol (1967) 1.49
Unusual lectin-binding properties of a herpes simplex virus type 1-specific glycoprotein. J Virol (1981) 1.48
Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules. Virology (1981) 1.39
Incomplete complex oligosaccharides in semliki forest virus envelope proteins arrested within the cell in the presence of monensin. J Mol Biol (1982) 1.32
Initial glycosylation of proteins with acetylgalactosaminylserine linkages. Proc Natl Acad Sci U S A (1979) 1.27
Transport of newly synthesized vesicular stomatitis viral glycoprotein to purified Golgi membranes. J Cell Biol (1981) 1.21
Isolation and properties of a temperature-sensitive mutant (ts 412) of an influenza A virus recombinant with a ts lesion in the gene coding for the nonstructural protein. Virology (1981) 1.11
COMPARATIVE EFFECTS OF L-HISTIDINE ON THE ACTIVITIES OF 5'-NUCLEOTIDASE AND ALKALINE PHOSPHATASE. J Biol Chem (1963) 1.09
Influence of the infection with lipid-containing viruses on the metabolism and pools of phospholipid precursors in animal cells. Eur J Biochem (1978) 0.88
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature (1993) 5.73
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron (1995) 5.42
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J (1994) 5.02
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
Purification to homogeneity and properties of two D-alanine carboxypeptidases I From Escherichia coli. J Biol Chem (1976) 4.66
Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature (1992) 4.43
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol (1994) 4.20
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature (1992) 4.16
Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein. Nature (1993) 4.09
Recent expansion of Toxoplasma through enhanced oral transmission. Science (2003) 3.88
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43
Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity. Nat Neurosci (1998) 3.37
The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25
Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med (1998) 3.23
Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. Nature (1984) 3.15
High-dose intravenous gammaglobulin for Kawasaki disease. Lancet (1984) 3.10
Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J (1993) 3.08
Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 3.08
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother (1991) 3.05
Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med (1996) 2.95
Efficacy of meningococcal vaccine and barriers to vaccination. JAMA (1998) 2.92
Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J Virol (1976) 2.91
The effect of zinc supplementation on pregnancy outcome. JAMA (1995) 2.87
Smoking and mortality among older men and women in three communities. N Engl J Med (1991) 2.86
Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84
Identification and analysis of eukaryotic promoters: recent computational approaches. Trends Genet (2001) 2.78
Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J (1995) 2.76
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Influenza viruses cause hemolysis and fusion of cells. Virology (1981) 2.73
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem (1998) 2.71
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J (1986) 2.62
Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem (1994) 2.59
Impact of education for physicians on patient outcomes. Pediatrics (1998) 2.54
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest (1993) 2.52
Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer. World J Surg (2000) 2.51
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans. J Biol Chem (1984) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Tetanus toxin-mediated cleavage of cellubrevin impairs exocytosis of transferrin receptor-containing vesicles in CHO cells. J Cell Biol (1994) 2.46
Molecular biology and evolution of filoviruses. Arch Virol Suppl (1993) 2.45
Uptake of screening and prevention in women at very high risk of breast cancer. Lancet (2001) 2.45
The complete DNA sequence of myxoma virus. Virology (1999) 2.44
Comparison of open and laparoscopic live donor nephrectomy. Ann Surg (1997) 2.43
Ampulla cardiomyopathy ('Takotusbo' cardiomyopathy)--reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J (2000) 2.39
Interactions of Marburg virus nucleocapsid proteins. Virology (1998) 2.37
The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion. Virology (1970) 2.37
Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. Blood (2000) 2.30
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg (1990) 2.28
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26
How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res (1998) 2.25
Pause on avian flu transmission research. Science (2012) 2.24
Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology (2000) 2.21
Takling the 'hideous scourge': the creation of the venereal disease treatment centres in early twentieth-century Britain. Soc Hist Med (1992) 2.20
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol (1994) 2.17
Folic acid safety and toxicity: a brief review. Am J Clin Nutr (1989) 2.17
In vitro peptidoglycan polymerization catalysed by penicillin binding protein 1b of Escherichia coli K-12. FEBS Lett (1980) 2.14
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel. Ann Oncol (2009) 2.14
Disassembly of the reconstituted synaptic vesicle membrane fusion complex in vitro. EMBO J (1995) 2.13
Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13
Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun (1989) 2.13
The delirium symptom interview: an interview for the detection of delirium symptoms in hospitalized patients. J Geriatr Psychiatry Neurol (1992) 2.11
A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells. Mol Biol Cell (1998) 2.11
Glycosylation and oligomerization of the spike protein of Marburg virus. Virology (1991) 2.11
Partial caries removal and cariostatic materials in carious primary molar teeth: a randomised controlled clinical trial. Br Dent J (2004) 2.10
Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J Virol (1997) 2.09
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol (2000) 2.09
General anaesthesia: who decides, and why? Br Dent J (1994) 2.08
Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J (2000) 2.08
Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie (1994) 2.07
Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. Anesthesiology (1992) 2.07
Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem (1994) 2.06
Association of influenza virus proteins with cytoplasmic fractions. Virology (1974) 2.00
Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00
Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. Proc Natl Acad Sci U S A (2000) 1.99
Acute health effects of the Sea Empress oil spill. J Epidemiol Community Health (1999) 1.99
Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J (1986) 1.98
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97
Dilution is effective in reducing infusion phlebitis in peripheral parenteral nutrition: an experimental study in rabbits. Nutrition (1998) 1.96
Membrane fusion machinery: insights from synaptic proteins. Cell (1993) 1.96
Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96
The prevalence and nature of recent self-reported changes in general dental practice in a sample of English general dental practitioners. Br Dent J (2004) 1.93
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem (1986) 1.92
Photoplethysmography. Part 1. Comparison with laser Doppler flowmetry. Med Biol Eng Comput (1991) 1.92